CIK 0001048477
- Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680397820
- Phone
- +1 415-506-6700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,163,748
- in 1 filing
Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-28 | FUCHS HENRY J President, Worldwide R&D | Grant or award | +36,440 | 180,534 | ||
| 2023-02-28 | FUCHS HENRY J President, Worldwide R&D | Grant or award | +18,220 | 198,754 | ||
| 2023-02-28 | FUCHS HENRY J President, Worldwide R&D | Grant or award | +13,392 | 212,146 | ||
| 2023-02-28 | BIENAIME JEAN JACQUES Chief Executive Officer | Grant or award | +89,700 | 410,024 | ||
| 2023-02-28 | BIENAIME JEAN JACQUES Chief Executive Officer | Grant or award | +44,860 | 454,884 | ||
| 2023-02-28 | BIENAIME JEAN JACQUES Chief Executive Officer | Grant or award | +32,972 | 487,856 | ||
| 2023-02-24 | Davis George Eric EVP, Chief Legal Officer | Exercise or conversion | +1,474 | $67.81 | $100K | 56,725 |
| 2023-02-24 | Davis George Eric EVP, Chief Legal Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −1,474 | 0 | ||
| 2023-02-13 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +6,000 | $67.81 | $407K | 326,324 |
| 2023-02-13 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −6,000 | $109.15 | $655K | 320,324 |
| 2023-02-10 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +15,000 | $67.81 | $1.0M | 335,324 |
| 2023-02-10 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −15,000 | $110.11 | $1.7M | 320,324 |
| 2023-02-10 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −15,000 | 178,130 | ||
| 2023-02-10 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −6,000 | 172,130 | ||
| 2023-02-07 | BIENAIME JEAN JACQUES Chief Executive Officer | Gift | −200 | 247,333 | ||
| 2023-02-07 | BIENAIME JEAN JACQUES Chief Executive Officer | Gift | +100 | 100 | ||
| 2023-02-07 | BIENAIME JEAN JACQUES Chief Executive Officer | Gift | +100 | 100 | ||
| 2023-01-25 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Exercise or conversion | +49,000 | $67.81 | $3.3M | 90,088 |
| 2023-01-25 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Sale | −44,825 | $115.65 | $5.2M | 45,263 |
| 2023-01-25 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Sale | −4,175 | $116.15 | $485K | 41,088 |
Page 18 of 23 · 450 trades